Benefiting Humanity

Prof. Avigdor Scherz

Photodynamic Therapy of Cancer

12.09.2010

Plants and Agriculture, Benefiting Humanity

Prof. Avigdor Scherz studied photosynthesis, the process by which plants capture sunlight and convert it into useful energy. Together with Prof....

Prof. Irun Cohen

A Vaccine for Type 1 Diabetes

12.09.2010

Disease, Drugs & Diagnostics, Benefiting Humanity

DIAPEP 277, a vaccine based on Cohen’s research, was shown in clinical trials to alleviate the condition of people with juvenile (type 1) diabetes...

Prof. Eli Canaani

First Discovery of Cancer Produced by Protein Fusion

12.09.2010

Disease, Drugs & Diagnostics, Benefiting Humanity

Prof. Eli Canaani’s research provided the foundation for the development of Glivec, the first drug based on the molecular understanding of a specific...

Prof. Emeritus Nechama Haran-Ghera

Hormone Erythropoietin for Treating Multiple Myeloma

12.09.2010

Disease, Drugs & Diagnostics, Benefiting Humanity

Haran-Ghera’s research provided the scientific basis for clinical trials of erythropoietin in multiple myeloma and for testing the effects of this...

Prof. Avraham Amsterdam

Asthma Drug Used to Enhance Ovarian and Lung Cancer Treatment

12.09.2010

Disease, Drugs & Diagnostics, Benefiting Humanity

Prof. Avraham Amsterdam revealed that theophylline, a widely used asthma drug, makes ovarian and lung cancer cells more vulnerable to common...

Prof. Amos Breskin

Advanced Radiation Detectors

12.09.2010

Space & Physics, Benefiting Humanity

Prof. Amos Breskin develops advanced radiation detectors, which have an important impact on many fields of research, such as particle, nuclear and...

Prof. Yair Reisner

Hepatitis B and C Therapies

12.09.2010

Disease, Drugs & Diagnostics, Benefiting Humanity

Prof. Yair Reisner developed mice with functioning human immune systems. These laboratory animals can be used for research on a broad range of human...

Prof. Ephraim Katzir

Development of Synthetic Antigens

12.09.2010

Biochemistry, Benefiting Humanity

In the 1950s, Prof. Ephraim Katzir developed simple synthetic models, known as polyamino acids, that made it easier to study the properties of...

Prof. Ephraim Katzir d

Immobilized Enzymes Used in the Pharmaceutical Industry

12.09.2010

Biochemistry, Benefiting Humanity

In the 1960s, Prof. Ephraim Katzir developed a method for binding enzymes to a variety of insoluble carriers. Enzymes speed up many chemical...

Prof. Yair Reisner

Method Preventing Transplant Rejection

12.09.2010

Disease, Drugs & Diagnostics, Benefiting Humanity

Prof. Yair Reisner studied molecules of various sugars and sugar-binding proteins called lectins, which allow cells to identify one another and latch...

Pages

Top Stories

MRI Gets a Nano-Sized Upgrade

Whisker Whisperers

Cracking the Disorder

Slimming with Mitch

Press Releases

Wake-Up Call for Dormant Cancer

The Master Switch Turning Immune Cells into Cancer Eradicators